Home LiteratureArticle Details
PMID: 16533158 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

The isoprostanes - unique products of arachidonate peroxidation: their role as mediators of oxidant stress.

Current pharmaceutical design ·Vol. 12 ·No. 8 ·2006-00-00 ·Pages 895-902

Morrow JD

Abstract

The isoprostanes (IsoPs) are a series of novel prostaglandin-like compounds formed in vivo in humans from the free radical-catalyzed peroxidation of arachidonate independent of the cyclooxygenase. While quantification of these compounds is a highly accurate measure of oxidant stress in vivo in humans, IsoPs also possess potent biological activity and likely mediate certain aspects of oxidative injury. The purpose of this review is to summarize selected aspects of our knowledge regarding the bioactivity of the IsoPs. I will first briefly highlight mechanisms involved in IsoP formation. Subsequently, I will discuss the biological activities of certain IsoPs that are formed in abundance in vivo and focus on two compounds, 15-F(2t)-IsoP and 15-E(2t)-IsoP, that have been studied in the greatest detail. This review will then examine, at a molecular level, mechanisms by which IsoPs exert their bioactivity. It has been shown that they are ligands for various eicosanoid receptors, in particular, the thromboxane receptor. In addition, I will discuss the controversial evidence that a unique IsoP receptor(s) exists. Finally, I will offer avenues for future research related to the development of pharmacological approaches to modulate IsoP formation and action in vivo and thus decrease the pathophysiological sequelae of oxidative injury.

MeSH Terms
Animals Arachidonic Acid/metabolism Blood Platelets/drug effects Bronchoconstrictor Agents/pharmacology Dinoprost/analogs & derivatives,metabolism,pharmacology Dinoprostone/analogs & derivatives,metabolism Drug Design Humans Isoprostanes/biosynthesis,metabolism Kidney/blood supply,drug effects Lipid Peroxidation Lung/blood supply,drug effects Oxidative Stress Pulmonary Circulation/drug effects Receptors, Prostaglandin E/drug effects Receptors, Prostaglandin E, EP2 Subtype Receptors, Thromboxane/metabolism Vasoconstrictor Agents/pharmacology
Chemicals
Bronchoconstrictor Agents Isoprostanes PTGER2 protein, human Receptors, Prostaglandin E Receptors, Prostaglandin E, EP2 Subtype Receptors, Thromboxane Vasoconstrictor Agents 8-epi-prostaglandin F2alpha Arachidonic Acid Dinoprost Dinoprostone 8-isoprostaglandin E2
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Morrow Jason D
Department of Medicine, Vanderbilt University, Nashville, TN 37232-6602, USA. [email protected]
Article Info
Journal
Current pharmaceutical design
Abbr.
Curr Pharm Des
ISSN
1381-6128
Published
2006-00-00
Pages
895-902
Language
English
Region
United Arab Emirates
NLM ID
9602487
Subset
IM
Grants
NCI NIH HHS · CA77839 · United States
NIDDK NIH HHS · DK48831 · United States
NIGMS NIH HHS · GM15431 · United States
NCRR NIH HHS · RR00095 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]